Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-7 of  7 results for ""GLUCAGON-like peptides""

Your Filters

Publisher : frontline medical communications
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Safety of Once-weekly Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes.

  • Authors : Frias JP; National Research Institute, Los Angeles, California, USA.

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Glucagon-Like Peptide 1/Glucagon-Like Peptide 1/Glucagon-Like Peptide 1/*analogs & derivatives ; Glucagon-Like Peptides/Glucagon-Like Peptides/Glucagon-Like Peptides/*analogs & derivatives

  • Source: The Journal of family practice [J Fam Pract] 2018 Jun; Vol. 67 (6 suppl), pp. S25-S34.Publisher: Frontline Medical Communications Country of Publication: United States NLM ID: 7502590 Publication Model: Print

Record details

Read Online Read More Add to Saved list
×
Academic Journal

An Overview of the Burden of Illness and the Role of Once-Weekly Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Type 2 Diabetes.

  • Authors : Brunton SA; Department of Pharmacy Practice, Roseman University of Health Sciences, Salt Lake City, Utah, USA.

Subjects: Cost of Illness*; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Glucagon-Like Peptides/Glucagon-Like Peptides/Glucagon-Like Peptides/*analogs & derivatives

  • Source: The Journal of family practice [J Fam Pract] 2018 Jun; Vol. 67 (6 suppl), pp. S3-S7.Publisher: Frontline Medical Communications Country of Publication: United States NLM ID: 7502590 Publication Model: Print

Record details

Read Online Read More Add to Saved list
×
Academic Journal

A Clinical Overview of Once-weekly Glucagon-like Peptide-1 Receptor Agonists.

  • Authors : Unger J; Unger Concierge Primary Care Medical Group, Rancho Cucamonga, CA, and UC Riverside School of Medicine, Riverside, CA, USA.

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Glucagon-Like Peptides/Glucagon-Like Peptides/Glucagon-Like Peptides/*analogs & derivatives ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*administration & dosage

  • Source: The Journal of family practice [J Fam Pract] 2018 Jun; Vol. 67 (6 suppl), pp. S1-S2.Publisher: Frontline Medical Communications Country of Publication: United States NLM ID: 7502590 Publication Model: Print

Record details

Read Online Read More Add to Saved list
×
Academic Journal

How do these 3 diabetes agents compare in reducing mortality?

Subjects: SODIUM-glucose cotransporters; GLUCAGON-like peptides; MORTALITY

  • Source: Journal of Family Practice. Mar2019, Vol. 68 Issue 2, p99-101. 3p.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Pathophysiology of type 2 diabetes mellitus: potential role of incretin-based therapies.

Subjects: TYPE 2 diabetes treatment; GLUCOSE; INSULIN

  • Source: Journal of Family Practice. Sep2010 Supplement, Vol. 59, pS5-S9. 5p.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Clinical Efficacy of Once-weekly Glucagonlike Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes.

  • Authors : Bailey TS; AMCR Institute Inc., Escondido, CA, USA.

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Glucagon-Like Peptide 1/Glucagon-Like Peptide 1/Glucagon-Like Peptide 1/*analogs & derivatives ; Hypoglycemia/Hypoglycemia/Hypoglycemia/*prevention & control

  • Source: The Journal of family practice [J Fam Pract] 2018 Jun; Vol. 67 (6 suppl), pp. S14-S24.Publisher: Frontline Medical Communications Country of Publication: United States NLM ID: 7502590 Publication Model: Print

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment: Glucagon-Like Peptide-1 Receptor Agonists.

  • Authors : Edelman SV; Professor of Medicine, University of California San Diego, Veterans Affairs Medical Center, San Diego, California, USA.

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/*agonists ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*therapeutic use

  • Source: The Journal of family practice [J Fam Pract] 2017 Oct; Vol. 66 (10 Suppl), pp. S12-S16.Publisher: Frontline Medical Communications Country of Publication: United States NLM ID: 7502590 Publication Model: Print

Record details

Read Online Read More Add to Saved list
×
  • 1-7 of  7 results for ""GLUCAGON-like peptides""